Neurol. praxi. 2015;16(2):108-110

Encephalitis of unclear origin with suspected Epstein-Barr virus aetiology

MUDr. Anna Šefčíková, MUDr. Miloslav Dvorák, PhD.
Neurologické oddelenie NsP, Spišská Nová Ves

The present case report describes a 50-year-old female patient two years after kidney transplantation on permanent immunosuppressive therapy who suddenly developed reversible dementia syndrome. Given the 14-3-3 protein positivity and a history of organ transplant from an unknown donor, a diagnosis of prion infection was taken into consideration, among other things. The subsequent reversal of the clinical course with a relatively sudden abatement of symptoms supported the diagnosis of atypically proceeding neuroinfection without demonstration of the aetiological agent. During follow-up, the patient experienced recurrence of symptoms a month later, with imaging and laboratory testing performed showing encephalitis of unclear origin, most likely Epstein-Barr virus encephalitis.

Keywords: encephalitis, Epstein-Barr virus, 14-3-3 protein

Published: May 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šefčíková A, Dvorák M. Encephalitis of unclear origin with suspected Epstein-Barr virus aetiology. Neurol. praxi. 2015;16(2):108-110.
Download citation

References

  1. Connelly KP, DeWitt LD. Neurologic complications of infectious mononucleosis. Pediatr Neurol. 1994; 10(3): 181-184. Go to original source... Go to PubMed...
  2. Doutlík S. Infekce a nervová soustava. Praha: Avicenum; 1987: 110-113.
  3. Gilden DH, Mahalingam R, Dohra RJ, Tyler KL. Herpesvirus Infections of the Nervous System. Nat Clin Pract neurol. 2007; 3(2): 82-94. Go to original source... Go to PubMed...
  4. Kalita J, Maurya PK, Kumar B, Misra UK. Epstein Barr virus encephalitis: Clinical diversity and radiological similarity. Neurol India. 2011; 59: 605-607. Go to original source... Go to PubMed...
  5. Martelius T, Lappalainen M, Palomäki M, Anttila VJ. Clinical characteristics of patiens with Epstein Barr virus in cerebrospinal fluid. BMC Infectious Diseases. 2011; 11: 281. Go to original source... Go to PubMed...
  6. Matěj R, Nováková J, Fiala J, Koukolík F, Rusina R. Vyšetřování proteinu 14-3-3 v mozkomíšním moku - klinicko-patologická korelace. Cesk Slov Neurol N. 2008; 71/104 (6): 695-699.
  7. Muayqil T, Gronseth G, Camicioli R. Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creuzfeldt-Jakob disease: report of the guideline development subcommittee of American Academy of neurology. Neurology. 2012; 79(14): 1499-1506. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.